Filing Details

Accession Number:
0001127602-23-027415
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-15 09:23:16
Reporting Period:
2023-11-14
Accepted Time:
2023-11-15 09:23:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1141722 C James Foster 251 Ballardvale Street
Wilmington MA 01887
Chairman, President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-14 5,620 $178.05 202,643 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,328 Indirect 2021 GRAT
Common Stock 11,000 Indirect 2022 GRAT
Common Stock 20,000 Indirect 2023 GRAT
Common Stock 340 Indirect By Trust
Common Stock 750 Indirect By Trust
Common Stock 2,250 Indirect By Trust
Common Stock 10,000 Indirect Held By Spouse
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $177.99 to $178.11. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.